Catheter ablation vs. anti-arrhythmic drug therapy for ventricular tachycardia in ischaemic heart disease: a meta-analysis of randomized controlled trials
In ischaemic heart disease and VT, CA compared with anti-arrhythmic drugs is associated with a reduction of appropriate ICD therapy, cardiovascular re-hospitalization, and adverse events with benefits most evident versus sotalol.
Authors
- Christiane Jungen (ORCID: https://orcid.org/0000-0003-4062-3299)
- Stefan Stojković (ORCID: https://orcid.org/0000-0002-4285-5416)
- Bert Vandenberk (ORCID: https://orcid.org/0000-0001-8296-920X)
- Giacomo Mugnai (ORCID: https://orcid.org/0000-0003-4733-9418)
- Boldizsar Kovacs (ORCID: https://orcid.org/0000-0002-7972-5199)
- A Marco Del Castillo (ORCID: https://orcid.org/0000-0002-5322-2067)
- Kevin Vernooy (ORCID: https://orcid.org/0000-0002-8818-5964)
- Laura Perrotta (ORCID: https://orcid.org/0000-0002-4322-1183)
- Stefan Kurath‐Koller (ORCID: https://orcid.org/0000-0003-3435-714X)
- Francesco Santoro (ORCID: https://orcid.org/0000-0001-9909-6513)
- Leon Dinshaw (ORCID: https://orcid.org/0000-0002-1473-5716)
Institutions
- University of Foggia (IT)
- University of Verona (IT)
- Medical University of Graz (AT)
- Maastricht University Medical Centre (NL)
- University Hospital of Bern (CH)
- Maastricht University (NL)
- Hospital Universitario 12 De Octubre (ES)
- Sana Kliniken AG (DE)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- West German Heart and Vascular Center Essen (DE)
- Medical University of Vienna (AT)
- KU Leuven (BE)
Publication Details
- Journal
- EP Europace
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1093/europace/euaf302
- Citations
- 1
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39